Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Nano-X Imaging

Clinicaltrial registered28 Oct 2026

Nano-X Imaging

28 Oct 2026: Trial registered · Evaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different Diseases. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
28 Oct 2026
Title
Evaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different Diseases
Conditions
Fracture, Erosion
Phase
Not applicable
Study Type
Interventional
Status
Recruiting
Countries
Israel
Country
Israel
Reference
NCT07900412
Location
Israel
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Nano-X Imaging

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Israel

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.